Clinical features of neuroendocrine prostate cancer

BACKGROUND: Neuroendocrine prostate cancer (NEPC) is an aggressive variant of prostate cancer that may arise de novo or in patients previously treated with hormonal therapies for prostate adenocarcinoma as a mechanism of resistance. Despite being important to recognise, the clinical features of NEPC...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Cancer
Hlavní autoři: Conteduca, Vincenza, Oromendia, Clara, Eng, Kenneth W., Bareja, Rohan, Sigouros, Michael, Molina, Ana, Faltas, Bishoy M., Sboner, Andrea, Mosquera, Juan Miguel, Elemento, Olivier, Nanus, David M., Tagawa, Scott T., Ballman, Karla V., Beltran, Himisha
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6803064/
https://ncbi.nlm.nih.gov/pubmed/31525487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2019.08.011
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky